INTELESENS LTD

Their core work

INTELESENS is a Belfast-based medical technology SME whose core work is the development of wearable biosensors for continuous cardiac monitoring — specifically detecting arrhythmias through wrist and arm-worn devices. Their participation in WASTCArD indicates hands-on hardware and signal processing expertise, translating clinical-grade cardiac diagnostics into unobtrusive wearable form factors. They also engage with the broader connected health ecosystem, as shown by their involvement in CHESS, a research training network for connected health technologies. In EU consortia, they function as an industry-side specialist, offering real-world product development experience within academic research networks.

What they specialise in

How they've shifted over time

Both H2020 projects began in 2015, so there is no meaningful temporal shift to analyze — INTELESENS entered and exited the H2020 programme within a single cohort of projects. No keywords are available in the data to map early versus late focus. What can be said is that even within this narrow window, they were active in two complementary areas: device-level sensing (WASTCArD) and ecosystem-level connected health infrastructure (CHESS), suggesting a deliberate effort to position at both the hardware and platform layers of digital health.

With only two projects, both starting in 2015 and no subsequent H2020 activity visible, it is unclear whether INTELESENS scaled its EU project engagement independently or shifted focus entirely to commercial product development — a pattern common among medtech SMEs that use EU projects as early R&D leverage before pivoting to market.

How they like to work

INTELESENS has never led an H2020 project — they join as participant or third-party partner, consistent with an SME that contributes industry expertise rather than leading research agendas. Despite only two projects, they accumulated 25 unique consortium partners across 12 countries, suggesting participation in large multi-partner MSCA training networks where industry partners are deliberately distributed. This profile makes them a reliable specialist contributor rather than a coordination-heavy partner.

INTELESENS has connected with 25 unique partners across 12 countries from just two projects — an unusually broad reach for an SME with minimal coordinator experience, explained by their participation in MSCA network schemes (RISE and ITN-ETN) which inherently involve large, geographically distributed consortia. Their network is European in scope, concentrated in the connected health and medical technology research community.

What sets them apart

INTELESENS occupies a specific niche as a Northern Irish medtech SME with proven wearable cardiac sensor expertise — a combination that is rare in the UK's H2020 participant base, which skews toward London-based or university-affiliated entities. For consortium builders, they offer genuine industry-side product credibility in wearable health monitoring without the overhead of a large industrial partner. Their dual participation in both a sensing-focused project and a connected health training network suggests they can bridge hardware development and clinical ecosystem conversations.

Highlights from their portfolio

• WASTCArD
  Directly maps to INTELESENS's presumed core product — wrist-worn cardiac arrhythmia detection — making this the clearest evidence of their technical identity.
• CHESS
  As an MSCA-ITN-ETN training network for connected health researchers, CHESS signals INTELESENS's interest in shaping the next generation of the field, not just delivering components to it.